|
1
|
Buckwalter JA, Mankin HJ and Grodzinsky
AJ: Articular cartilage and osteoarthritis. Instr Course Lect.
54:465–480. 2005.
|
|
2
|
Ramos YF, Bos SD, Lakenberg N, Böhringer
S, den Hollander WJ, Kloppenburg M, Slagboom PE and Meulenbelt I:
Genes expressed in blood link osteoarthritis with apoptotic
pathways. Ann Rheum Dis. 73:1844–1853. 2014.
|
|
3
|
Ren YH: The epidemiological investigation
of sports injury in elite athletes. Zhong guo yundong yi xue.
19:377–386. 2000.In Chinese.
|
|
4
|
Minns RJ and Muckle DS: The role of the
meniscus in an instability model for osteoarthritis in the rabbit
knee. Br J Exp Pathol. 63:18–24. 1982.
|
|
5
|
Setton LA, Mow VC, Müller FJ, Pita JC and
Howell DS: Mechanical behavior and biochemical composition of
canine knee cartilage following periods of joint disuse and disuse
with remobilization. Osteoarthritis Cartilage. 5:1–16. 1997.
|
|
6
|
Buckwalter JA and Martin JA: Sports and
osteoarthritis. Curr Opin Rheumatol. 16:634–639. 2004.
|
|
7
|
Lequesne M: Sport practice and
osteoarthritis of the limbs. Science & Sports. 19:281–285.
2004.In French.
|
|
8
|
Nusse R: Wnt signaling in disease and in
development. Cell Res. 15:28–32. 2005.
|
|
9
|
Nelson WJ and Nusse R: Convergence of Wnt,
beta-catenin, and cadherin pathways. Science. 303:1483–1487.
2004.
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt method. Methods. 25:402–408. 2001.
|
|
11
|
Aigner T, Rose J, Martin J and Buckwalter
J: Aging theories of primary osteoarthritis: From epidemiology to
molecular biology. Rejuvenation Res. 7:134–145. 2004.
|
|
12
|
Loeser RF, Goldring SR, Scanzello CR and
Goldring MB: Osteoarthritis: A disease of the joint as an organ.
Arthritis Rheum. 64:1697–1707. 2012.
|
|
13
|
Benito MJ, Veale DJ, Fitzgerald O, van den
Berg WB and Bresnihan B: Synovial tissue inflammation in early and
late osteoarthritis. Ann Rheum Dis. 64:1263–1267. 2005.
|
|
14
|
Sellam J and Berenbaum F: The role of
synovitis in patho-physiology and clinical symptoms of
osteoarthritis. Nat Rev Rheumatol. 6:625–635. 2010.
|
|
15
|
Ma CH, Lv Q, Cao Y, Wang Q, Zhou XK, Ye BW
and Yi CQ: Genes relevant with osteoarthritis by comparison gene
expression profiles of synovial membrane of osteoarthritis patients
at different stages. Eur Rev Med Pharmacol Sci. 18:431–439.
2014.
|
|
16
|
Eckstein F, Hudelmaier M and Putz R: The
effects of exercise on human articular cartilage. J Anat.
208:491–512. 2006.
|
|
17
|
Almekinders LC and Garrett WE: Sports
injuries. Curr Probl Surg. 37:331–338. 2000.
|
|
18
|
Strutt D: Frizzled signalling and cell
polarisation in Drosophila and vertebrates. Development.
130:4501–4513. 2003.
|
|
19
|
Luyten FP, Tylzanowski P and Lories RJ:
Wnt signaling and osteoarthritis. Bone. 44:522–527. 2009.
|
|
20
|
Wodarz A and Nusse R: Mechanisms of Wnt
signaling in development. Annu Rev Cell Dev Biol. 14:59–88.
1998.
|
|
21
|
Zhu M, Tang D, Wu Q, Hao S, Chen M, Xie C,
Rosier RN, O'Keefe RJ, Zuscik M and Chen D: Activation of
beta-catenin signaling in articular chondrocytes leads to
osteoarthritis-like phenotype in adult beta-catenin conditional
activation mice. J Bone Miner Res. 24:12–21. 2009.
|
|
22
|
Piters E, Boudin E and Van Hul W: Wnt
signaling: A win for bone. Arch Biochem Biophys. 473:112–116.
2008.
|
|
23
|
Burrage PS, Mix KS and Brinckerhoff CE:
Matrix metalloproteinases: Role in arthritis. Front Biosci.
11:529–543. 2006.
|
|
24
|
Kawaguchi H: Regulation of osteoarthritis
development by Wnt-beta-catenin signaling through the endochondral
ossification process. J Bone Miner Res. 24:8–11. 2009.
|
|
25
|
Yuasa T, Otani T, Koike T, Iwamoto M and
Enomoto-Iwamoto M: Wnt/β-catenin signaling stimulates matrix
catabolic genes and activity in articular chondrocytes: Its
possible role in joint degeneration. Lab Invest. 88:264–274.
2008.
|
|
26
|
Guohui Y: Bone morphogenetic protein in
the repair of articular cartilage injury. J Clin Rehabil Tissue Eng
Res. 46:8669–8672. 2010.
|
|
27
|
Scharstuhl A, Vitters EL, van der Kraan PM
and van den Berg WB: Reduction of osteophyte formation and synovial
thickening by adenoviral overexpression of transforming growth
factor beta/bone morphogenetic protein inhibitors during
experimental osteoarthritis. Arthritis Rheum. 48:3442–3451.
2003.
|
|
28
|
Dell'Accio F, De Bari C, El Tawil NM,
Barone F, Mitsiadis TA, O'Dowd J and Pitzalis C: Activation of WNT
and BMP signaling in adult human articular cartilage following
mechanical injury. Arthritis Res Ther. 8:R1392006.
|
|
29
|
Grcevic D, Jajic Z, Kovacic N, Lukic IK,
Velagic V, Grubisic F, Ivcevic S and Marusic A: Peripheral blood
expression profiles of bone morphogenetic proteins, tumor necrosis
factor-superfamily molecules and transcription factor Runx2 could
be used as markers of the form of arthritis, disease activity, and
therapeutic responsiveness. J Rheumatol. 37:246–256. 2010.
|
|
30
|
Neuhold LA, Killar L, Zhao W, Sung ML,
Warner L, Kulik J, Turner J, Wu W, Billinghurst C, Meijers T, et
al: Postnatal expression in hyaline cartilage of constitutively
active human collagenase-3 (MMP-13) induces osteoarthritis in mice.
J Clin Invest. 107:35–44. 2001.
|
|
31
|
Nakashima A and Tamura M: Regulation of
matrix metallopro-teinase-13 and tissue inhibitor of matrix
metalloproteinase-1 gene expression by WNT3A and bone morphogenetic
protein-2 in osteoblastic differentiation. Front Biosci.
11:1667–1678. 2006.
|
|
32
|
Topol L, Chen W, Song H, Day TF and Yang
Y: Sox9 inhibits Wnt signaling by promoting beta-catenin
phosphorylation in the nucleus. J Biol Chem. 284:3323–3333.
2009.
|
|
33
|
Hwang SG, Yu SS, Lee SW and Chun JS:
Wnt-3a regulates chon-drocyte differentiation via c-Jun/AP-1
pathway. FEBS Lett. 579:4837–4842. 2005.
|
|
34
|
Miclea RL, Karperien M, Bosch CA, van der
Horst G, van der Valk MA, Kobayashi T, Kronenberg HM, Rawadi G,
Akçakaya P, Löwik CW, et al: Adenomatous polyposis coli-mediated
control of beta-catenin is essential for both chondrogenic and
osteogenic differentiation of skeletal precursors. BMC Dev Biol.
9:262009.
|
